# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5030413 | Binding | Displacement of [3H]-PGE2 from human EP3 receptor assessed as inhibition constant incubated for 2 hrs by TopCount scintillation counting method | Homo sapiens | 27 | ALA5029194 | single protein format | Scientific Literature | |
2. | ALA5030414 | Functional | Antagonist activity at human EP3 receptor expressed in CHO-K1 cells assessed as reduction in sulprostone induced inhibition of forskolin stimulated cAMP production incubated for 30 mins by TR-FRET assay | Homo sapiens | 25 | ALA5029194 | cell-based format | Scientific Literature | |
3. | ALA5030415 | Binding | Binding affinity to human EP1 receptor assessed as inhibition constant | Homo sapiens | 1 | ALA5029194 | single protein format | Scientific Literature | |
4. | ALA5030416 | Binding | Binding affinity to human EP2 receptor assessed as inhibition constant | Homo sapiens | 1 | ALA5029194 | single protein format | Scientific Literature | |
5. | ALA5030417 | Binding | Binding affinity to human EP4 receptor assessed as inhibition constant | Homo sapiens | 1 | ALA5029194 | single protein format | Scientific Literature | |
6. | ALA5030418 | Binding | Binding affinity to rat EP3 receptor assessed as inhibition constant | Rattus norvegicus | 1 | ALA5029194 | single protein format | Scientific Literature | |
7. | ALA5030419 | Functional | In vivo antagonist activity at ER3 receptor in Sprague-Dawley rat assessed as reversal of sulprostone induced reduction in circulating insulin levels at 10 times Ki, administered as iv infusion measured up to 30 mins after glucose administration by glucose tolerance test | Rattus norvegicus | 1 | ALA5029194 | organism-based format | Scientific Literature | |
8. | ALA5030420 | ADME | Free plasma concentration in Sprague-Dawley rat at 10 times Ki administered as iv infusion measured after 2 to 50 mins | Rattus norvegicus | 1 | ALA5029194 | organism-based format | Scientific Literature | |
9. | ALA5030421 | ADME | Cmax in Sprague-Dawley rat at 10 mg/kg, po measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
10. | ALA5030423 | ADME | AUClast in Sprague-Dawley rat at 10 mg/kg, po measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 2 | ALA5029194 | organism-based format | Scientific Literature | |
11. | ALA5030425 | ADME | Half life in Sprague-Dawley rat at 2 mg/kg, iv measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
12. | ALA5030426 | ADME | Clearance in Sprague-Dawley rat at 2 mg/kg, iv measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
13. | ALA5030427 | ADME | Volume of distribution at steady state in Sprague-Dawley rat at 2 mg/kg, iv measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
14. | ALA5030428 | ADME | Half life in Sprague-Dawley rat at 10 mg/kg, po measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
15. | ALA5030429 | ADME | AUC(0 to 24 hrs) in Sprague-Dawley rat at 10 mg/kg, po measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature | |
16. | ALA5030430 | ADME | Oral bioavailability in Sprague-Dawley rat at 10 mg/kg measured up to 24 hrs by LC-MS-MS analysis | Rattus norvegicus | 6 | ALA5029194 | organism-based format | Scientific Literature |